AI-extracted claim
“Dr. William Marks stated the Paradromics clinical trial will enroll 10 patients with disorders causing speech and limb paralysis, like stroke and ALS.”
Analyzed on 2026-09-19T04:40:33+00:00 · Last updated 2026-09-19
Plain language: Insufficient evidence was found to render a verdict.
Credibility score
out of 100
Based on 1 source
Low confidence
Original context
Show passage from source article
The trial will include 10 patients around the country with various disorders that cause speech and limb paralysis, such as stroke and amyotrophic lateral sclerosis, said Dr. William Marks, chief clinical officer of Paradromics.
Extracted from: ‘I Have a Lot to Say’: Brain Implant Helps a Disabled Patient Speak , The New York Times
Evidence
This analysis is based on a single source. Confidence is low.
Bias distribution of supporting sources
Mean bias -0.20
Community Takes
No Takes have been written on this claim yet. Sign in to write a Take.